Delivery Order SPE2DB20D9761-SPE2DB25FB3LB
- Not listed
- The Defense Logistics Agency awarded a $41,661.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation to supply this contraceptive implant device. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 3, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price contracting without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of May 29, 2025. This delivery order was issued without a set-aside designation and represents a call against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The awardee, a woman-owned small business pharmaceutical wholesaler based in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of September 17, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The place of performance is Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. The contract, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,811.55 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. This award was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis despite its...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with a ceiling value of $26,038.50. The award, announced on August 18, 2025, is classified as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is...
- SPE2DB20D9761Indefinite Delivery Contract
- SPE2DB20D9761-SPE2DB25FB3LBDelivery Order
The Defense Logistics Agency awarded a $16,612.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a specific product requisition under DMS's larger indefinite delivery contract with DLA, which is valued at $499,999,999 and remains valid through November 2026. This award exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. Mirena systems, a contraceptive implant product, falls within the company's demonstrated portfolio of pharmaceutical and medical device deliveries to DLA, which has consistently awarded the firm delivery orders for products ranging from specialty medications to vaccines and injectable treatments supporting military health facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 9/17/25 |